Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32374540!ä!32374540 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Rev+Med+Suisse 2020 ; 16 (692): 933-938 Nephropedia Template TP {{tp|p=32374540|t=2020. Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19 |pdf=|usr=}}{{32374540}} gab.com Text Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19 JO: Rev Med Suisse http://www.kidney.de/pget.php?&tw=1&pmid=32374540 #FOAvip Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease. Twit Text FOAVip Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19 ????Rev Med Suisse http://www.kidney.de/pget.php?&tw=1&pmid=32374540 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32374540 #FOAvip English Wikipedia <ref>{{Cite pmid|32374540}}</ref> Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19 #MMPMID32374540 Daccord C; Touilloux B; Von Garnier C Rev Med Suisse 2020[May]; 16 (692): 933-938 PMID32374540show ga Numerous patients with asthma or COPD are likely to be infected with SARS-CoV-2 virus. Although data is limited, patients with severe and/or uncontrolled asthma and those with COPD appear to be at increased risk of a more severe course of COVID-19 infection. Usual recommendations for management of asthma and COPD remain valid despite the ongoing epidemic. However, lung function testing and nebulisers should be performed with caution during the COVID-19 pandemic due to a potential risk of virus aerosolisation and contagion during the procedure. Particular care must be taken to identify and protect patients who are particularly vulnerable to COVID-19 infection. Asthma and COPD treatments should be pursued and adapted to ensure optimal control of the lung disease throughout the epidemic, thus reducing the risk of severe COVID-19 disease. |*Asthma/complications/therapy[MESH] |*Coronavirus Infections/complications/epidemiology[MESH] |*Pandemics[MESH] |*Pneumonia, Viral/complications/epidemiology[MESH] |*Pulmonary Disease, Chronic Obstructive/complications/therapy[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Humans[MESH] |Risk Factors[MESH]Prise en charge de l'asthme et de la BPCO en situation de pandemie de (epmc).pdf DeepDyve Pubget Overpricing